Blocknomi
Key Highlights NTRA stock rises following Japanese regulatory clearance for Signatera in colorectal cancer. Japan’s PMDA grants first-ever approval for CRC molecular residual disease testing. Commercial availability in Japan targeted…
Related articles
-
Ethereum Foundation lays off 20% of workforce in major restructuring
Crypto.News Published 23.06.2026 18:12
-
Toss Bank And Solana Foundation Team Up On Stablecoin Remittance Test
NewsBTC Published 22.06.2026 10:33
-
‘That’s the wrong question’: Bitwise CIO reframes bitcoin bottom debate, points to long-term drivers
The Block Published 16.06.2026 10:13
-
Franklin Templeton Bets Bigger on Crypto After Major Acquisition
BeInCrypto Published 22.06.2026 17:08
-
Fervo Energy (FRVO) Stock Surges 8% on Nvidia Partnership Despite Quarterly Loss
Blocknomi Published 22.06.2026 12:56
-
SEC Proposes Scrapping Reg NMS Trade-Through Rule In Move To Ease Market Complexity
NewsBTC Published 18.06.2026 20:30
-
Cwinz: Where Seamless Integration Meets High-Performance Crypto Gaming
BlockchainReporter Published 18.06.2026 08:38
-
Andrew Tate loses nearly $86,000 longing and shorting Bitcoin
Cointelegraph Published 19.06.2026 15:05